Evidence map›Paper›PMID 34656996›Full record

Trial reportThorax2023

Automatic oxygen titration versus constant oxygen flow rates during walking in COPD: a randomised controlled, double-blind, crossover trial.

Tessa Schneeberger, Inga Jarosch, Daniela Leitl, Rainer Gloeckl, Wolfgang Hitzl, Clancy John Dennis, Tatjana Geyer, Carl-Peter Criée, Andreas Rembert Koczulla, Klaus Kenn

3 registry-linked trialsOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Thorax, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03803384 nacompletednot on this map

Effects of an Auto-Regulating Oxygen System Compared to Constant-Flow Oxygen During Walking in Hypoxemic COPD Patients - a Randomized Controlled Trial

TypeinterventionalSponsorSchön Klinik Berchtesgadener LandRan2019 to 2019Enrolled55ConditionsCOPDArmsOxygen therapy
NCT06465654 nacompletednot on this mapstarted 2024, after this paper: background citation

OXYWILD - Automated Oxygen Titration With O2matic During Walking in Patients With Fibrotic Interstitial Lung Diseases (F-ILD): A Randomized Study

TypeinterventionalSponsorJanne Hastrup JensenRan2024 to 2025Enrolled29ConditionsFibrosis Lung, Respiratory TherapyArmsAutomated variable dose oxygen treatment, Fixed dose oxygen treatment
NCT06545851 narecruitingnot on this map

Automatic Oxygen Titration Versus Constant Oxygen Flow Rates During Exercise Training in Hypoxemic People With Chronic Lung Disease - a Randomized, Double-blind, Controlled Cross-over Pilot Study

TypeinterventionalSponsorSchön Klinik Berchtesgadener LandRan2023 to 2024Enrolled15ConditionsHypoxaemia, Chronic Lung DiseaseArmsOxygen therapy - constant oxygen flow, Oxygen therapy - automatic titrating oxygen flow
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Digital twins for chronic lung diseases.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  10. Review
  11. Supplemental oxygen and noninvasive ventilation.European respiratory review : an official journal of the European Respiratory Society · 2023
    Article
  12. 2022 Brazilian Thoracic Association recommendations for long-term home oxygen therapy.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Tessa SchneebergerDepartment of Pulmonary Rehabilitation, Philipps-University of Marburg, Marburg, Hessen, Germany TSchneeberger@schoen-klinik.de.
Inga JaroschDepartment of Pulmonary Rehabilitation, Philipps-University of Marburg, Marburg, Hessen, Germany.
Daniela LeitlDepartment of Pulmonary Rehabilitation, Philipps-University of Marburg, Marburg, Hessen, Germany.
Rainer GloecklDepartment of Pulmonary Rehabilitation, Philipps-University of Marburg, Marburg, Hessen, Germany.
Wolfgang HitzlResearch Office (Biostatistics), Paracelsus Medical University Salzburg, Salzburg, Austria.
Clancy John DennisFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Tatjana GeyerMedical School, Philipps-University of Marburg, Marburg, Hessen, Germany.
Carl-Peter CriéeDepartment of Sleep and Respiratory Medicine, Evangelical Hospital Goettingen-Weende, Bovenden, Germany.
Andreas Rembert KoczullaDepartment of Pulmonary Rehabilitation, Philipps-University of Marburg, Marburg, Hessen, Germany.
Klaus KennDepartment of Pulmonary Rehabilitation, Philipps-University of Marburg, Marburg, Hessen, Germany.
Philipps University of Marburg · DESchön Klinik Berchtesgadener Land · DEEvangelisches Krankenhaus Göttingen-Weende · DEParacelsus Medical University · ATThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleIn patients with COPD, oxygen (O

methodsFifty participants completed this prospective randomised controlled, double-blind, crossover trial. Participants performed two endurance shuttle walk tests (ESWTs) with: (1) exercise titrated CFOS (ESWT

resultsParticipants (median (IQR): age 66 (59, 70) years, FEV

conclusionIn patients with hypoxaemia with severe COPD the use of ATOS leads to significant, clinically relevant improvements in walking endurance time, SpO TRIAL REGISTRATION NUMBER: NCT03803384.

Indexed as

OxygenPulmonary Disease, Chronic ObstructiveAgedCross-Over StudiesDyspneaExercise ToleranceHumansHypoxiaProspective StudiesWalkingOxygenambulatory oxygen therapyCOPD pathologyexercise

Identifiers

PMID34656996
PMCPMC10086462
OpenAlexW3205481236

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.